In this issue, Dr. J. E. Poulsen has reported the final course and postmortem findings of the well-known patient who developed Sheehan's syndrome while suffering from diabetic retinopathy with impaired vision.
The report of substantial regression of the retinopathy (DIABETES 2:7-12, 1953 ) triggered the subsequent effort to evaluate the role of the pituitary gland in diabetic retinopathy.
Cautious students and investigators recognize the dangers of drawing inferences based on data obtained in a single patient. Controversy continues concerning the desirability of ablating the pituitary or adrenal glands in diabetic subjects with advancing retinitis. Nevertheless, Dr. Poulsen's second report provides the longest continual study of a patient with documented hypopituitarism with diabetic retinopathy whose retinal lesion regressed so as to save vision. This long period (fifteen years) from the beginning of remission to death without recurrence of retinal hemorrhages will serve to encourage further studies of induced hypopituitarism or adrenal insufficiency in comparable patients with advancing retinopathy in attempting to control this disabling complication.
The persistence of diffuse intercapillary glomerulosclerosis and progressive renal insufficiency in Dr. Poulsen's case, as in many others with induced hypopituitarism, indicates that the renal basement membrane changes may not be modified by hypopituitarism. The significant gain has been the cessation of retinal capillary hemorrhages and their sequelae in sufficient numbers of cases of advancing diabetic retinitis proliferans so as to warrant continued careful clinical and experimental investigation of hypopituitarism, however induced, and its role in arresting diabetic retinitis. Allen Hennes was a fine person and a valued friend. A little over two years ago the glow of his health flickered, and he knew then that he should have reduced his responsibilities to a more average level. Characteristically, the threat was ignored and his range of commitments extended; at the same time family life with his wife and two sons deepened, becoming an even greater source of satisfaction to him.
His independent mind and quiet sense of fun made him a good companion under any circumstances. More than upright in the conduct of his own life, he was sympathetic to the shortcomings of others and his judgments were rarely harsh. An underlying shyness always had to be overcome before his convictions could assert themselves, but he had his convictions, and from the earliest years he thought for himself.
His capacity for hard work and sense of competition quickly placed his laboratory in the ranks of those doing first class research in lip id metabolism, and a steady flow of abstracts and papers on this subject have characterized the past five years of his work. His recent demonstration of abnormal patterns of fatty acid synthesis by platelets from diabetic patients and by platelets from apparent nondiabetics with coronary artery disease, led him to postulate an abnormal pattern of lipid synthesis as a fundamental defect in diabetes.* He scintillated with projects and ideas derived from his work and contributed with keen perception at the numerous meetings to which his interests led him. He was an activist in the best sense of the word, whether teaching on the wards, pouring over data, or sailing in his boat. Yet he was as interested in a fine painting as he was in good food.
The loss to his family and friends is great and will be felt for a long time. But his effort is not lost and it assuredly will serve as a foundation for new work. For those of us who worked with him, it is difficult to realize he is no longer in the laboratory or busy at his desk.
LAWRENCE POWER, M.D.
Detroit
# The Editor wishes to express his own deep sense of loss in this untimely event. The death of Dr. Hennes interrupted correspondence which had led to a planned special article by him, offering a new theory as to the nature of diabetes as a specific fault in lipid metabolism. He last wrote: "Would you be interested in considering for publication a rather concise review of our work with human blood cells from diabetics and "prediabetics" along with our studies of the effects of insulin on formation of individual fatty acids in adipose tissue? I believe that I can really make a rather coherent new sort of hypothesis of diabetes out of both aspects of these studies. The studies with adipose tissue show very clearly that, at least in the buffer system we're using, incorporation of glucose into palmitate is the most important pathway of disposal of glucose, accounting for about 60 per cent of the glucose utilized for lipid formation. On the other hand, we consistently have found decreased formation of palmitate in platelets from diabetics under circumstances where insulin levels in plasma are presumably normal or even increased. The whole thing suggests that formation of palmitate may be defective in the diabetic and makes a reasonably coherent hypothesis. It seems to me most hypotheses of diabetes have been more or less shot down recently. I'm about ready to run up another one."
Colleagues in the American Diabetes Association have also expressed their sympathy and regret the loss of a valued scientist approaching the peak of his investigative career. Verbatim Summary. Focal muscular degeneration in two diabetics is described. In both instances the muscular lesion was excised on the grounds of clinical suspicion of tumor. The gross and microscopical pictures agreed with those of muscular degeneration following ischemia. Accordingly, the vascular lesions that were demonstrated, diabetic microangiopathy and arteriosclerosis, may have been of importance in the pathogenesis. , Gianni; Sonenberg, Martin; and Merlino, Mario J. (Div. of Total twenty-four-hour urinary excretion of hydroxyproline (OHP) was measured in patients with diabetic retinopathy before and after hypophysectomy and in twelve volunteer subjects. The OHP levels were significantly decreased in the diabetic patients before hypophysectomy; the levels after operation were increased to the control range. One patient with clinical hypopituitarism was given 53 mg. of human growth hormone over a four-day period with no apparent effect upon her low excretory rate of OHP. C.R.S. The peripheral glucose and free fatty acid (FFA) metabolism was studied in twenty-four adults ranging from lean to grossly obese using the isolated forearm technic with catheterization of the antecubital vein and brachial artery. Oral glucose tolerance tests were performed with blood samples obtained before and for 150 minutes after glucose loading. The rate of glucose uptake showed a close negative correlation with the degree of skin-fold thickness; the nonobese females had a well-defined rise in blood glucose at sixty minutes which was twice that of the obese. The arterial FFA fell more slowly in the obese but the same low levels were eventually achieved
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